Skin Grafting Device Market Size, Share & Trends Analysis Report By Device Type, By Application (Burn Care, Chronic Wound Care), By End-use (Ambulatory Surgical Centers, Specialty Clinics Dermatology Clinics), By Region, And Segment Forecasts, 2025 - 2030

Skin Grafting Device Market Size, Share & Trends Analysis Report By Device Type, By Application (Burn Care, Chronic Wound Care), By End-use (Ambulatory Surgical Centers, Specialty Clinics Dermatology Clinics), By Region, And Segment Forecasts, 2025 - 2030


Skin Grafting Device Market Size & Trends

The global skin grafting device market size was valued at USD 141.0 million in 2024 and is anticipated to grow at a CAGR of 5.63% from 2025 to 2030. The market is driven by rising awareness about aesthetic procedures, high demand for skin grafts, and increasing awareness regarding the available treatment options. According to CUTISS, one of the pioneers in the development of the world’s first automated platform for large-scale skin tissue production, in 2023, over 20,000 burn patients were documented in the U.S., with 10% suffering from significant burns that affected more than 20% of their body area. As climate change leads to rising temperatures, the incidence of burn injuries has been on the rise. While most burns occur in private homes, they also represent a significant injury risk in combat situations and other high-risk professions.

Skin grafting is a relatively recent advancement in surgical techniques that entails replacing damaged skin with skin from the surrounding area to promote wound healing. This procedure is recommended for various conditions such as skin infections, severe burns, trauma, pressure ulcers, skin cancer, and reconstructive surgery. Skin grafting systems comprise the necessary equipment, materials, consumables, and instruments used throughout the procedure, including those for creating a mesh, collecting samples, and applying the final graft. To treat wounds involving significant tissue loss, a full-thickness skin graft is necessary. This type of graft requires the complete thickness of skin from the donor site rather than just the upper two layers. After the graft is carefully positioned over the wound and secured with a covering for optimal healing, it is harvested from the healthy area.

Supportive measures from governments, including reimbursement schemes covering approximately 70-100% of therapy expenses, encourage individuals to opt for sophisticated treatments for burns. Additionally, both government bodies and non-profit entities, such as the World Health Organization (WHO) and the American Burn Association (ABA), play significant roles in increasing awareness. The WHO actively collaborates with the International Society for Burn Injuries, among other organizations, aiming to refine burn treatment methods and implement preventive measures against burn injuries worldwide.

Moreover, strategic initiatives by major companies, including the introduction of new products and the undertaking of mergers and acquisitions, contribute to market growth. For instance, in October 2024, CUTISS AG, a life science company specializing in tissue engineering therapy and regenerative medicine, successfully performed the first-ever grafting of denovoSkin, their autologous, bio-engineered dermo-epidermal skin graft. This innovative procedure was carried out as a compassionate reconstructive measure and marks the company's inaugural case in the United States. The U.S. Food & Drug Administration (FDA) granted authorization for the procedure under a single patient Investigational New Drug (IND) application, which was executed by the skilled surgical team at Massachusetts General Hospital (MGH).

Moreover, rising cases of burn injuries are another key factor fueling the market growth. Below are some general statistics on burn injuries based on data from the World Health Organization (WHO) and the American Burn Association:
  • An estimated 180,000 deaths occur each year worldwide due to burn injuries.
  • In the U.S., there are approximately 486,000 burn injuries that require medical treatment each year, with about 40,000 of those requiring hospitalization.
  • In the U.S., fire/flame burns are the most common type of burn injury (43%), followed by scalds (34%), contact burns (9%), electrical burns (4%), chemical burns (3%), and other types of burns (7%).
  • Each year, around 1 person per 100,000 people require inpatient hospitalization at a burn center in the U.S.
Global Skin Grafting Device Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global skin grafting device market report on the basis of device type, application, end-use, and region:
  • Device Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Dermatomes
  • Meshers
  • Accessories
  • ApplicationOutlook (Revenue, USD Million, 2018 - 2030)
  • Burn Care
  • Chronic Wound Care
  • Reconstructive Surgery
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Dermatology Clinics
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Norway
  • Denmark
  • Sweden
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
Please note The report will be delivered in 4-8 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Device Type
1.2.2. Application
1.2.3. End Use
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary Applications
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Applications
1.9. List of Primary Applications
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Regional outlook
2.4. Competitive Insights
Chapter 3. Skin Grafting Device Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising incidence of accidents and burns
3.2.1.2. Increasing prevalence of chronic wounds
3.2.1.3. Advancements in surgical techniques
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of procedures
3.2.2.2. Complex surgical techniques
3.3. Skin Grafting Device Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Skin Grafting Device Market - Segment Analysis, by Device Type, 2018 - 2030 (USD Million)
4.1. Skin Grafting Device Market: Device Type Outlook and Key Takeaways
4.2. Skin Grafting Device Market: Device Type Movement Analysis
4.3. Skin Grafting Device Market Estimates & Forecast, by Device Type (USD Million)
4.4. Dermatomes
4.4.1. Dermatomes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Meshers
4.5.1. Meshers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Accessories
4.6.1. Accessories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Skin Grafting Device Market - Segment Analysis, by Application, 2018 - 2030 (USD Million)
5.1. Skin Grafting Device Market: Application Outlook and Key Takeaways
5.2. Skin Grafting Device Market: Application Movement Analysis
5.3. Skin Grafting Device Market Estimates & Forecast, by Application (USD Million)
5.4. Burn Care
5.4.1. Burn Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Chronic Wound Care
5.5.1. Chronic Wound Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Reconstructive Surgery
5.6.1. Reconstructive Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Skin Grafting Device Market - Segment Analysis, by End Use, 2018 - 2030 (USD Million)
6.1. Skin Grafting Device Market: End Use Outlook and Key Takeaways
6.2. Skin Grafting Device Market: End Use Movement Analysis
6.3. Skin Grafting Device Market Estimates & Forecast, by Application (USD Million)
6.4. Hospitals
6.4.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Ambulatory Surgical Centers
6.5.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Specialty Clinics
6.6.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Dermatology Clinics
6.7.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Skin Grafting Device Market: Regional Estimates & Trend Analysis
7.1. Regional Dashboard
7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
7.3. North America
7.3.1. U.S.
7.3.1.1. Key country dynamics
7.3.1.2. Regulatory framework/ reimbursement structure
7.3.1.3. Competitive scenario
7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.3.2. Canada
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/ reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.3.3. Mexico
7.3.3.1. Key country dynamics
7.3.3.2. Regulatory framework/ reimbursement structure
7.3.3.3. Competitive scenario
7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework/ reimbursement structure
7.4.1.3. Competitive scenario
7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. France
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.4.4. Italy
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.4.5. Spain
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.4.6. Norway
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.4.8. Denmark
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. India
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.5.4. Australia
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Argentina
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. UAE
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Kuwait
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Recent Developments & Impact Analysis by Key Market Participants
8.3. Company Market Share Analysis, 2024
8.4. Key Company Profiles
8.4.1. Zimmer Biomet
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. B. Braun SE
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Aygün
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. De Soutter Medical
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Stryker
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Integra LifeSciences
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Rudolf Storz GmbH
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Exsurco Medical, Inc.
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. NOUVAG AG
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. Surtex Instruments Limited
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
8.4.11. De Soutter Medical
8.4.11.1. Company overview
8.4.11.2. Financial performance
8.4.11.3. Product benchmarking
8.4.11.4. Strategic initiatives
8.4.12. Mölnlycke Health Care AB
8.4.12.1. Company overview
8.4.12.2. Financial performance
8.4.12.3. Product benchmarking
8.4.12.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings